TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pierre Fabre Pharma Norden AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
18,754
|
21,828
|
20,320 |
Financial expenses |
31
|
52
|
28 |
Earnings before taxes |
573
|
724
|
567 |
EBITDA |
548
|
796
|
604 |
Total assets |
14,128
|
11,710
|
14,207 |
Current assets |
14,046
|
11,627
|
14,104 |
Current liabilities |
11,948
|
9,440
|
12,285 |
Equity capital |
2,180
|
2,270
|
1,922 |
- share capital |
36
![]() |
36
|
39 |
Employees (average) |
16
|
15
|
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
15.4%
|
19.4%
|
13.5% |
Turnover per employee |
1,172
|
1,455
|
1,451 |
Profit as a percentage of turnover |
3.1%
|
3.3%
|
2.8% |
Return on assets (ROA) |
4.3%
|
6.6%
|
4.2% |
Current ratio |
117.6%
|
123.2%
|
114.8% |
Return on equity (ROE) |
26.3%
|
31.9%
|
29.5% |
Change turnover |
-3,138
|
3,155
|
2,026 |
Change turnover % |
-14%
|
17%
|
11% |
Chg. No. of employees |
1
![]() |
1
![]() |
1 |
Chg. No. of employees % |
7%
![]() |
7%
|
8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.